Compare Illumina, Inc. (ILMN) vs Uber Technologies Inc (UBER) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Uber Technologies Inc — how do they compare? Illumina, Inc. trades at $189.66 (market cap $27.94B), while Uber Technologies Inc trades at $72.36 (market cap $146.91B). The key difference: Uber Technologies Inc is far larger — about 5.3× Illumina, Inc.'s market cap, and Illumina, Inc. is trading nearer its 52-week high, Uber Technologies Inc nearer its low. Which is the better fit depends on your goals.
| ILMN | UBER | |
|---|---|---|
Market Cap | $27.94B | $146.91B |
Sector | Health | Industrials |
52-Week High | $194.33 | $100.10 |
52-Week Low | $91.00 | $68.61 |
Enterprise Value | $29.33B | $153.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Uber's stock trades at $72.46, down 2.13% on the day, reflecting near-term pressure amid a bearish technical signal. Fundamentally, the company shows strong revenue growth, with 2025 revenue reaching $52.02 billion and net income of $10.05 billion, though profitability margins have moderated from 2024 peaks. Recent news highlights strategic shifts toward autonomous vehicles, including robotaxi pilots in Europe and cost-cutting measures like HR layoffs and AI spending caps to improve efficiency.
The outlook remains positive with an 81.67% analyst buy rating and a $107.64 consensus price target, suggesting significant upside. Key risks include execution challenges in autonomous vehicle integration, competitive pressures in key markets like India, and potential margin compression. Investors should weigh strong cash flow generation and market leadership against evolving regulatory and technological landscapes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Uber Technologies Inc
Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →
